Medium-Term Management Plan

1. Medium-term management plan 21-25 basic strategies

Basic Strategies Lay the foundation for growth strategies during the transformation period toward VISION 30

In order to realize the new value in the VISION 30, develop precision medicine and around the pill solutions

*Considering the differences in people's genes, environment, and lifestyle, provide appropriate healthcare to appropriate patients at appropriate times.

2. Research and Development

(1) Central nervous system area strategies

With ALS, which has abundant drug discovery information, as the entry point, we will quickly identify genes of diseases for intractable neurological diseases, which share causative genes and pathophysiology, and take on the challenge of creating new modalities.

(2) Immuno-inflammation area strategies

Developing immunophenotypes drugs for diseases like systemic sclerosis and systemic lupus erythematosus with various symptoms and few effective drugs

(3) Vaccine area strategies

3. Business Development

Strengthen business in the US and Japan, and develop around the pill solutions to create new customer contact points

U.S. and Europe	Establish growth drivers Expansion of business scale by introducing in-house developed products
Japan	Maintain Japan as the mother market Deepening the current businesses and broadening to a new business foundation
China and Asia	Maintain Japan as the mother market Deepening the current businesses and broadening to a new business foundation

4. Management Base

Fortify the management base and optimally allocate management resources

Strategic Investment	Accelerating investment to strengthen business and collaborate with outside parties
Organization and HR Reform	Promoting the specialty, diversity, and digitization of organizations and people towards innovation
Digital Transformation	Building digital infrastructure to enhance productivity of growth strategies and value chains